Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,404
Out of 4,979 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $158.64 | +10.31% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $78.78 | -23.84% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $20.83 | +236.05% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $113.11 | +1.67% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $84.36 | -5.17% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.34 | +5,497.01% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $158.64
Upside: +10.31%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $78.78
Upside: -23.84%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $20.83
Upside: +236.05%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $113.11
Upside: +1.67%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $84.36
Upside: -5.17%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.34
Upside: +5,497.01%